Rujia J. Mi

Shenzhen, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

SLC30A9-mediated mitochondrial zinc homeostasis drives osteosarcoma chemoresistance by suppressing the mtDNA-cGAS-STING pathway.

SLC30A9-mediated mitochondrial zinc homeostasis drives osteosarcoma chemoresistance by suppressing the mtDNA-cGAS-STING pathway.

Journal: Life sciences
Published: March 12, 2026

Downregulation of ZFP36L1 contributes to methotrexate resistance in osteosarcoma through enhanced NHEJ DNA repair mechanisms.

Downregulation of ZFP36L1 contributes to methotrexate resistance in osteosarcoma through enhanced NHEJ DNA repair mechanisms.

Journal: Cell death & disease
Published: February 08, 2025

Erratum: ATF6 aggravates angiogenesis-osteogenesis coupling during ankylosing spondylitis by mediating FGF2 expression in chondrocytes.

Erratum: ATF6 aggravates angiogenesis-osteogenesis coupling during ankylosing spondylitis by mediating FGF2 expression in chondrocytes.

Journal: iScience
Published: January 16, 2024

Enhancer-mediated FOXO3 expression promotes MSC adipogenic differentiation by activating autophagy.

Enhancer-mediated FOXO3 expression promotes MSC adipogenic differentiation by activating autophagy.

Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: September 19, 2023

EFHD1 promotes osteosarcoma proliferation and drug resistance by inhibiting the opening of the mitochondrial membrane permeability transition pore (mPTP) by binding to ANT3.

EFHD1 promotes osteosarcoma proliferation and drug resistance by inhibiting the opening of the mitochondrial membrane permeability transition pore (mPTP) by binding to ANT3.

Journal: Cellular and molecular life sciences : CMLS
Published: August 07, 2023

Author Correction: Super enhancers targeting ZBTB16 in osteogenesis protect against osteoporosis.

Author Correction: Super enhancers targeting ZBTB16 in osteogenesis protect against osteoporosis.

Journal: Bone research
Published: June 26, 2023

SIRPA enhances osteosarcoma metastasis by stabilizing SP1 and promoting SLC7A3-mediated arginine uptake.

SIRPA enhances osteosarcoma metastasis by stabilizing SP1 and promoting SLC7A3-mediated arginine uptake.

Journal: Cancer letters
Published: June 24, 2023

Low expression of ZFP36L1 in osteosarcoma promotes lung metastasis by inhibiting the SDC4-TGF-β signaling feedback loop.

Low expression of ZFP36L1 in osteosarcoma promotes lung metastasis by inhibiting the SDC4-TGF-β signaling feedback loop.

Journal: Oncogene
Published: June 24, 2023

Super enhancers targeting ZBTB16 in osteogenesis protect against osteoporosis.

Super enhancers targeting ZBTB16 in osteogenesis protect against osteoporosis.

Journal: Bone research
Published: December 25, 2022

Impairment of APPL1/Myoferlin facilitates adipogenic differentiation of mesenchymal stem cells by blocking autophagy flux in osteoporosis.

Impairment of APPL1/Myoferlin facilitates adipogenic differentiation of mesenchymal stem cells by blocking autophagy flux in osteoporosis.

Journal: Cellular and molecular life sciences : CMLS
Published: May 24, 2022

DAPK1 Interacts with the p38 Isoform MAPK14, Preventing Its Nuclear Translocation and Stimulation of Bone Marrow Adipogenesis.

DAPK1 Interacts with the p38 Isoform MAPK14, Preventing Its Nuclear Translocation and Stimulation of Bone Marrow Adipogenesis.

Journal: Stem cells (Dayton, Ohio)
Published: November 15, 2021

ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway.

ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway.

Journal: Journal of experimental & clinical cancer research : CR
Published: July 02, 2021
Showing 1-12 of 17

Last Updated: 09/26/2026